World's Best Scientists 2026 revealed!
Stefani Spranger

Stefani Spranger

D-Index & Metrics

Immunology

D-Index
50
Citations
19280
World Ranking
4181
National Ranking
1906

Stefani Spranger publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Stefani Spranger sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 167 publications — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Stefani Spranger D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Stefani Spranger sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 50 D-Index — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Stefani Spranger is affiliated with MIT in the United States and has a substantial body of work primarily in medicine, immunology, and microbiology. Their research focuses on several intersecting areas within these fields, including oncology, molecular biology, and cancer research.

The main topics of Spranger's work include:

  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Vaccines and immunoinformatics approaches
  • Immune cells in cancer

Frequent publication venues for Spranger include:

  • Regular and Young Investigator Award Abstracts
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal for ImmunoTherapy of Cancer
  • Immunity
  • Cancer Immunology Research

Spranger collaborates regularly with several co-authors, notably:

  • Maria Zagorulya
  • Brendan Horton
  • Duncan M. Morgan
  • K. Dane Wittrup
  • Elen Torres-Mejia

Recent publications by Stefani Spranger include:

  • "Increased demand for NAD+ relative to ATP drives aerobic glycolysis" (2020, Molecular Cell)
  • "Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity" (2021, Immunity)
  • "Direct and Indirect Regulators of Epithelial-Mesenchymal Transition-Mediated Immunosuppression in Breast Carcinomas" (2020, Cancer Discovery)
  • "Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer" (2023, Immunity)
  • "Lack of CD8 + T cell effector differentiation during priming mediates checkpoint blockade resistance in non-small cell lung cancer" (2021, Science Immunology)

Best Publications

  • Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

    Stefani Spranger;Riyue Bao;Thomas F. Gajewski

  • Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells.

    Stefani Spranger;Robbert M. Spaapen;Yuanyuan Zha;Jason Williams

  • STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors

    Seng Ryong Woo;Mercedes Beatriz Fuertes;Leticia Corrales;Stefani Spranger

  • Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy

    Weiyi Peng;Jie Qing Chen;Chengwen Liu;Shruti Malu

  • Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.

    Stefani Spranger;Daisy Dai;Brendan Horton;Thomas F. Gajewski

  • Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8 + T cells directly within the tumor microenvironment

    Stefani Spranger;Holly K Koblish;Brendan Horton;Peggy A Scherle

  • Impact of oncogenic pathways on evasion of antitumour immune responses

    Stefani Spranger;Thomas F. Gajewski

  • WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers

    Jason J. Luke;Riyue Bao;Randy F. Sweis;Stefani Spranger

  • Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment

    Thomas F Gajewski;Seng-Ryong Woo;Yuanyuan Zha;Robbert Spaapen

  • Innate immune signaling and regulation in cancer immunotherapy

    Leticia Corrales;Vyara Matson;Blake Flood;Stefani Spranger

  • Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma.

    Stefani Spranger;Jason J Luke;Riyue Bao;Yuanyuan Zha

  • Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer.

    Randy F. Sweis;Stefani Spranger;Riyue Bao;Gladell P. Paner

  • Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity.

    Ellen Duong;Tim B. Fessenden;Emi Lutz;Teresa Dinter

  • Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy

    Lijie Zhai;Stefani Spranger;David C. Binder;Galina Gritsina

  • Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment

    Stefani Spranger

  • Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment

    Thomas F. Gajewski;Leticia Corrales;Jason Williams;Brendan Horton

  • Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL

    Daniel Nagel;Stefani Spranger;Michelle Vincendeau;Michael Grau

  • Future perspectives in melanoma research

    Paolo A. Ascierto;Sanjiv Agarwala;Gerardo Botti;Alessandra Cesano

  • WNT Signaling in Cancer Immunosurveillance.

    Lorenzo Galluzzi;Lorenzo Galluzzi;Stefani Spranger;Elaine Fuchs;Alejandro López-Soto

  • Lymphatic vessels regulate immune microenvironments in human and murine melanoma

    Amanda W. Lund;Marek Wagner;Manuel Fankhauser;Eli S. Steinskog

Frequent Co-Authors

Thomas F. Gajewski
Thomas F. Gajewski University of Chicago
Jason J. Luke
Jason J. Luke University of Pittsburgh
Paolo A. Ascierto
Paolo A. Ascierto National Institutes of Health
Lisa H. Butterfield
Lisa H. Butterfield University of California, San Francisco
Bernard A. FoxEarle
Bernard A. FoxEarle Earle A. Chiles Research Institute
Patrick Hwu
Patrick Hwu The University of Texas MD Anderson Cancer Center
Howard L. Kaufman
Howard L. Kaufman Harvard University
Lorenzo Galluzzi
Lorenzo Galluzzi Cornell University
Daniel Krappmann
Daniel Krappmann Ludwig-Maximilians-Universität München

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring complementary healthcare degrees can broaden career opportunities. Many choose to pursue nursing pathways, where specialized knowledge of the immune system enhances patient care. If looking for a seamless entry, some of the easy LPN programs to get into offer a valuable starting point, combining practical skills with foundational medical knowledge.

Advancing further, aspiring nurse practitioners may want to consider easiest NP program options. These programs help balance flexibility with comprehensive training, allowing students to deepen their clinical expertise and potentially focus on immune-related conditions.

For those passionate about mental health, particularly where immunity intersects with psychiatric care, enrolling in the best online psychiatric mental health nurse practitioner programs can provide excellent clinical placement opportunities alongside advanced curriculum.

Cost remains a critical factor for many students. Fortunately, several cheapest psychiatric nurse practitioner programs are available online, ensuring accessibility without compromising quality education.

Best Scientists Citing Stefani Spranger

Trending Scientists

Recently Published Articles